Bisphosphonates and osteoporosis.

作者信息

Sørensen O H, Storm T, Thamsborg G, Sørensen H A, Kollerup G, Steiniche T, Melsen F, Genant H K

机构信息

Department of Internal Medicine, Sundby Hospital, Copenhagen, Denmark.

出版信息

Osteoporos Int. 1993;3 Suppl 1:223-5. doi: 10.1007/BF01621913.

DOI:10.1007/BF01621913

PMID:8461567

Abstract

摘要

相似文献

Bisphosphonates and osteoporosis.

Osteoporos Int. 1993;3 Suppl 1:223-5. doi: 10.1007/BF01621913.

Bisphosphonates for osteoporosis--where do we go from here?

N Engl J Med. 2012 May 31;366(22):2048-51. doi: 10.1056/NEJMp1202619. Epub 2012 May 9.

The role of bisphosphonates in the prevention and treatment of osteoporosis.

Am J Med. 1993 Nov 30;95(5A):48S-52S. doi: 10.1016/0002-9343(93)90383-z.

Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.

Ann Med Interne (Paris). 2000 Oct;151(6):504-10.

[Bisphosphonates: pharmacology and use in the treatment of osteoporosis].

Nihon Rinsho. 2002 Mar;60 Suppl 3:350-8.

[Measurement of bone mineral density is necessary for monitoring of bisphosphonate treatment].

Clin Calcium. 2011 Jan;21(1):116-9.

[Prevention of fractures with therapeutic agents for osteoporosis].

Nihon Rinsho. 2004 Feb;62 Suppl 2:596-601.

[Drugs in development for the treatment of osteoporosis: Incadronate].

Nihon Rinsho. 2002 Mar;60 Suppl 3:538-43.

Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis.

Bone. 1996 Nov;19(5 Suppl):195S-198S. doi: 10.1016/s8756-3282(96)90165-9.

[Bisphosphonates in osteoporosis therapy. Standards and perspectives].

Orthopade. 2007 Feb;36(2):110-7. doi: 10.1007/s00132-006-1035-6.

引用本文的文献

Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling.

Calcif Tissue Int. 1996 Mar;58(3):166-9. doi: 10.1007/BF02526882.

Comparison of a semiquantitative and a quantitative method for assessing vertebral fractures in osteoporosis.

Osteoporos Int. 1994 May;4(3):154-61. doi: 10.1007/BF01623062.

本文引用的文献

Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients.

J Clin Invest. 1981 Oct;68(4):1086-92. doi: 10.1172/jci110331.

Preliminary observations of a form of coherence therapy for osteoporosis.

Calcif Tissue Int. 1984 May;36(3):341-3. doi: 10.1007/BF02405341.

Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

Science. 1969 Sep 19;165(3899):1262-4. doi: 10.1126/science.165.3899.1262.

The treatment of osteoporosis with disodium ethane-1, 1-diphosphonate.

J Lab Clin Med. 1971 Oct;78(4):574-84.

Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

Bone Miner. 1986 Feb;1(1):27-39.

Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.

Klin Wochenschr. 1988 Oct 3;66(19):976-84. doi: 10.1007/BF01738113.

Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.

J Clin Endocrinol Metab. 1988 Apr;66(4):747-53. doi: 10.1210/jcem-66-4-747.

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD.

Bone Miner. 1989 Jan;5(2):183-92. doi: 10.1016/0169-6009(89)90095-0.

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

Lancet. 1988 Jan 23;1(8578):143-6. doi: 10.1016/s0140-6736(88)92721-3.

Prevention of postmenopausal bone loss by tiludronate.

Lancet. 1989;2(8678-8679):1469-71. doi: 10.1016/s0140-6736(89)92927-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验